234 related articles for article (PubMed ID: 25166877)
1. Use of Scandinavian moist smokeless tobacco (snus) and the risk of atrial fibrillation.
Hergens MP; Galanti R; Hansson J; Fredlund P; Ahlbom A; Alfredsson L; Bellocco R; Eriksson M; Fransson EI; Hallqvist J; Jansson JH; Knutsson A; Pedersen N; Lagerros YT; Ostergren PO; Magnusson C
Epidemiology; 2014 Nov; 25(6):872-6. PubMed ID: 25166877
[TBL] [Abstract][Full Text] [Related]
2. Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival.
Hansson J; Galanti MR; Hergens MP; Fredlund P; Ahlbom A; Alfredsson L; Bellocco R; Engström G; Eriksson M; Hallqvist J; Hedblad B; Jansson JH; Pedersen NL; Trolle Lagerros Y; Ostergren PO; Magnusson C
J Intern Med; 2014 Jul; 276(1):87-95. PubMed ID: 24548296
[TBL] [Abstract][Full Text] [Related]
3. Moist smokeless tobacco (Snus) use and risk of Parkinson's disease.
Yang F; Pedersen NL; Ye W; Liu Z; Norberg M; Forsgren L; Trolle Lagerros Y; Bellocco R; Alfredsson L; Knutsson A; Jansson JH; Wennberg P; Galanti MR; Lager ACJ; Araghi M; Lundberg M; Magnusson C; Wirdefeldt K
Int J Epidemiol; 2017 Jun; 46(3):872-880. PubMed ID: 27940486
[TBL] [Abstract][Full Text] [Related]
4. High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men.
Östenson CG; Hilding A; Grill V; Efendic S
Scand J Public Health; 2012 Dec; 40(8):730-7. PubMed ID: 23117209
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction.
Arefalk G; Hambraeus K; Lind L; Michaëlsson K; Lindahl B; Sundström J
Circulation; 2014 Jul; 130(4):325-32. PubMed ID: 24958793
[TBL] [Abstract][Full Text] [Related]
6. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts.
Arefalk G; Hergens MP; Ingelsson E; Arnlöv J; Michaëlsson K; Lind L; Ye W; Nyrén O; Lambe M; Sundström J
Eur J Prev Cardiol; 2012 Oct; 19(5):1120-7. PubMed ID: 21828223
[TBL] [Abstract][Full Text] [Related]
7. Patterns of snus and cigarette use: a study of Norwegian men followed from age 16 to 19.
Grøtvedt L; Forsén L; Stavem K; Graff-Iversen S
Tob Control; 2013 Nov; 22(6):382-8. PubMed ID: 22634571
[TBL] [Abstract][Full Text] [Related]
8. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study.
Eliasson M; Asplund K; Nasic S; Rodu B
J Intern Med; 2004 Aug; 256(2):101-10. PubMed ID: 15257722
[TBL] [Abstract][Full Text] [Related]
9. Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: results from five pooled cohorts.
Carlsson S; Andersson T; Araghi M; Galanti R; Lager A; Lundberg M; Nilsson P; Norberg M; Pedersen NL; Trolle-Lagerros Y; Magnusson C
J Intern Med; 2017 Apr; 281(4):398-406. PubMed ID: 28164394
[TBL] [Abstract][Full Text] [Related]
10. Snus use, smoking and survival among prostate cancer patients.
Wilson KM; Markt SC; Fang F; Nordenvall C; Rider JR; Ye W; Adami HO; Stattin P; Nyrén O; Mucci LA
Int J Cancer; 2016 Dec; 139(12):2753-2759. PubMed ID: 27582277
[TBL] [Abstract][Full Text] [Related]
11. The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort.
Galanti MR; Rosendahl I; Wickholm S
Nicotine Tob Res; 2008 Feb; 10(2):315-23. PubMed ID: 18236296
[TBL] [Abstract][Full Text] [Related]
12. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies.
Hansson J; Galanti MR; Hergens MP; Fredlund P; Ahlbom A; Alfredsson L; Bellocco R; Eriksson M; Hallqvist J; Hedblad B; Jansson JH; Nilsson P; Pedersen N; Trolle Lagerros Y; Ostergren PO; Magnusson C
Eur J Epidemiol; 2012 Oct; 27(10):771-9. PubMed ID: 22722951
[TBL] [Abstract][Full Text] [Related]
13. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study.
Luo J; Ye W; Zendehdel K; Adami J; Adami HO; Boffetta P; Nyrén O
Lancet; 2007 Jun; 369(9578):2015-2020. PubMed ID: 17498797
[TBL] [Abstract][Full Text] [Related]
14. Swedish snuff (snus) and risk of cardiovascular disease and mortality: prospective cohort study of middle-aged and older individuals.
Titova OE; Baron JA; Michaëlsson K; Larsson SC
BMC Med; 2021 May; 19(1):111. PubMed ID: 33957912
[TBL] [Abstract][Full Text] [Related]
15. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
Gartner CE; Hall WD; Chapman S; Freeman B
PLoS Med; 2007 Jul; 4(7):e185. PubMed ID: 17608560
[TBL] [Abstract][Full Text] [Related]
16. Role of snus in initiation and cessation of tobacco smoking in Sweden.
Ramström LM; Foulds J
Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
[TBL] [Abstract][Full Text] [Related]
17. Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer.
Nordenvall C; Nilsson PJ; Ye W; Andersson TM; Nyrén O
Int J Cancer; 2013 Jan; 132(1):155-61. PubMed ID: 22492255
[TBL] [Abstract][Full Text] [Related]
18. Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies.
Byhamre ML; Araghi M; Alfredsson L; Bellocco R; Engström G; Eriksson M; Galanti MR; Jansson JH; Lager A; Lundberg M; Östergren PO; Pedersen NL; Trolle Lagerros Y; Ye W; Wennberg P; Magnusson C
Int J Epidemiol; 2021 Jan; 49(6):2041-2050. PubMed ID: 33347584
[TBL] [Abstract][Full Text] [Related]
19. Smoking, snus use and risk of right- and left-sided colon, rectal and anal cancer: a 37-year follow-up study.
Nordenvall C; Nilsson PJ; Ye W; Nyrén O
Int J Cancer; 2011 Jan; 128(1):157-65. PubMed ID: 20209500
[TBL] [Abstract][Full Text] [Related]
20. Using data on snus use in Sweden to compare different modelling approaches to estimate the population health impact of introducing a smoke-free tobacco product.
Djurdjevic S; Pecze L; Weitkunat R; Luedicke F; Fry J; Lee P
BMC Public Health; 2019 Oct; 19(1):1411. PubMed ID: 31664971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
